Latest Breaking News On - Company phase - Page 13 : comparemela.com

Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy s Disease)

Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy s Disease)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomGreat britainChristopher grunseichAlexandra macleanTahseen mozaffarJaclyn jaffeDrug administration or european medicines agencyNational institute of neurological disordersAnnji pharmaceutical coCompany phaseFortress biotech incUniversity of californiaLasker clinical research scholarLaboratory medicineEuropean union

Sigma Lithium Reports 1Q 2024 Results: May Shipment Priced at $1,290, Increased 25% From 1Q; Production Costs at $397/t, 2nd Lowest in Industry

Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.

Espíto santoMinas geraisMarc antoine laporteWilliam van breugelJarrett quinnHomero delboni jrPorfirio cabaleiro rodriguezCompany national instrumentLithium corporation sigmaCanada incPrimero group americasCompany grota do ciriloVenture exchangeCompany phaseRegulation services providerAccounting services

SIGMA LITHIUM REPORTS 1Q 2024 RESULTS: MAY SHIPMENT PRICED AT $1,290, INCREASED 25% FROM 1Q; PRODUCTION COSTS AT $397/t, 2ND LOWEST IN INDUSTRY

FIRST QUARTER 2024 HIGHLIGHTS ($ USD) Strengthened commercial position in May, achieving a premium price of USD $1,290/t, at a fixed formula of 9% of lithium.

Minas geraisEspíto santoWilliam van breugelHomero delboni jrJarrett quinnMarc antoine laportePorfirio cabaleiro rodriguezPrimero group americasLithium corporation sigmaRegulation services providerCanada incAccounting servicesVenture exchangeCompany grota do ciriloCompany phaseCompany national instrument

Clinical Trials Commenced For Promising Acclaim-3 Reqorsa® Immunogene Therapy In Combination With Tecentriq® To Treat Small Cell Lung Cancer: Genprex,

Clinical Trials Commenced For Promising Acclaim-3 Reqorsa® Immunogene Therapy In Combination With Tecentriq® To Treat Small Cell Lung Cancer: Genprex,
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoThomas gallagherGenentech tecentriqMoreno toscanoJosea moreno toscanoRodney varnerMark bergerTop company officersGenprex incUnited states incCompany phaseAmerican association for cancer researchBaltimore convention centerRoche groupTherapy focused

Resverlogix : Financial Statement Q1 2024

Resverlogix : Financial Statement Q1 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesKenneth zuerblisKelly mcneillResverlogix corpCompany phaseCompany net revenueDrug administrationDue to zenith capital corpZenith capital corpManagement services agreementResverlogix incInternational financial reporting standardsShenzhen hepalink pharmaceutical co ltdCompany audit committeeNational instrumentToronto stock exchange